BIOMERIEUX (BIM.PA) Stock Price, Quote, News and Overview
EPA:BIM - Euronext Paris - Matif - FR0013280286 - Common Stock - Currency: EUR
BIM.PA Quote, Performance and Key Statistics
BIOMERIEUX
EPA:BIM (1/23/2025, 4:56:19 PM)
112.55
+0.15 (+0.13%)
The current stock price of BIM.PA is 112.55 EUR. In the past month the price increased by 9.98%. In the past year, price increased by 7.1%.
BIM.PA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| IUI1.DE | INTUITIVE SURGICAL INC | 91.65 | 209.90B | ||
| 1ISRG.MI | INTUITIVE SURGICAL INC | 89.78 | 205.62B | ||
| ABL.DE | ABBOTT LABORATORIES | 26.41 | 198.32B | ||
| BSX.DE | BOSTON SCIENTIFIC CORP | 43.14 | 143.70B | ||
| 2M6.DE | MEDTRONIC PLC | 16.84 | 108.61B | ||
| 1MDT.MI | MEDTRONIC PLC | 16.67 | 107.51B | ||
| BOX.DE | BECTON DICKINSON AND CO | 18.21 | 66.56B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 24.33 | 61.19B | ||
| EWL.DE | EDWARDS LIFESCIENCES CORP | 26.12 | 39.43B | ||
| DC4.DE | DEXCOM INC | 51.69 | 32.91B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 19.77 | 23.97B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 19.77 | 23.97B |
Related screens
About BIM.PA
Company Profile
bioMérieux SA engages in the provision of in vitro diagnostic solutions, which determine the source of disease and contamination. The company is headquartered in Craponne, Auvergne-Rhone-Alpes and currently employs 14,651 full-time employees. The company went IPO on 2004-06-07. The firm designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The firm also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.
Company Info
BIOMERIEUX
376, chemin de l'Orme
Craponne AUVERGNE-RHONE-ALPES FR
Employees: 14651
Company Website: https://www.biomerieux.fr/
Investor Relations: https://www.biomerieux.com/en/finance
Phone: 33478872000
BIM.PA FAQ
What is the price of BIM.PA?
The current price of BIM.PA is 112.55 EUR.
What is the symbol for BIOMERIEUX?
The exchange symbol of BIOMERIEUX is BIM and it is listed on the Euronext Paris - Matif exchange.
On which exchange is BIM.PA listed?
BIM.PA is listed on the Euronext Paris - Matif exchange.
Is BIM.PA a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for BIM.PA, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of BIM.PA.
Does BIM.PA pay dividends?
BIM.PA has a dividend yield of 0.77%. The yearly dividend amount is currently 0.85.
What is the Price/Earnings (PE) ratio of BIM.PA?
The PE ratio for BIM.PA is 32.53. This is based on the reported non-GAAP earnings per share of 3.46 and the current share price of 112.55 EUR.
BIM.PA Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to BIM.PA. When comparing the yearly performance of all stocks, BIM.PA turns out to be only a medium performer in the overall market: it outperformed 56% of all stocks.
BIM.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to BIM.PA. While BIM.PA has a great health rating, its profitability is only average at the moment.
BIM.PA Financial Highlights
Over the last trailing twelve months BIM.PA reported a non-GAAP Earnings per Share(EPS) of 3.46. The EPS increased by 6.54% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.81% | ||
| ROA | 7.73% | ||
| ROE | 10.63% | ||
| Debt/Equity | 0.1 |
BIM.PA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 78% to BIM.PA. The Buy consensus is the average rating of analysts ratings from 20 analysts.
For the next year, analysts expect an EPS growth of 11.79% and a revenue growth 7.49% for BIM.PA